The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies
Coherent Identifier 20.500.12592/cc2ftd6

The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies

29 November 2023

Summary

Detailing how Australia’s Therapeutics Goods Administration conducted horizon scanning for new vaccines during the pandemic to assist ADB, this report is designed to help countries in Asia and the Pacific prepare for future outbreaks.It provides details of 16 vaccine manufacturers with novel and established vaccine technologies adapted to new pathogens like SARS-CoV-2, the virus that causes COVID-19. Offering information on their vaccine pipeline and partnerships, the report shows their approach to working with ADB’s developing member countries and can be used to inform decisions related to vaccine manufacturing and procurement.

Dimensions
8.5x11
ISBN
978-92-9270-481-0(print)
978-92-9270-482-7(electronic)
978-92-9270-483-4(ebook)
SKU
TCS230556-2
pages
54
DOI
http://dx.doi.org/10.22617/TCS230556-2
Published in
Philippines

Tags

covid-19 health communicable and vector-borne diseases health system development

Topics